Endothelium-derived relaxing factor (EDRF) has profound effects on the renal vasculature, the glomerular mesangium, and also affects renal salt excretion. EDRF stimulates guanylyl cyclases, which are thought to be heterodimers comprised of a and (3 subunits. Two a and two (3 isoforms have been identified thus far. However, the molecular composition of in vivo guanylyl cyclase-linked EDRF receptors is unknown. We used polymerase chain reaction to clone a portion of the rat a2 subunit. Guanylyl cyclase-linked EDRF receptor mRNA was detected in microdissected renal structures using a reverse transcription/polymerase chain reaction assay. The interlobular artery/afferent arteriole contained mRNA for the al, a2, and (31 subunits; a faint ,(2 band was found in 29% of experiments.
Introduction
Endothelium-derived relaxing factor (EDRF)' is produced in endothelial cells and acts in vascular smooth muscle cells to produce vasodilation. As expected, EDRF has profound effects 1 . Abbreviations used in this paper: CCD, cortical collecting duct; EDRF, endothelium-derived relaxing factor; ILA/ AA, interlobular artery/afferent arterioles.
on renal blood flow and glomerular filtration rate (reviewed in [ 1, 2 ] ). There is growing evidence that EDRF also affects renal sodium transport, since EDRF synthesis inhibitors alter renal salt excretion in the absence ofhemodynamic effects (3, 4) and inhibit oxygen consumption in suspensions ofouter medullary collecting ducts (5) . EDRF also inhibits short circuit current, a marker for sodium transport, in cultured mouse cortical collecting duct (CCD) cells (6) .
EDRF stimulates guanylyl cyclases, causing elevation of cyclic GMP concentration. Guanylyl cyclase-linked EDRF receptors, subsequently referred to as EDRF receptors, consist of two subunits (a and (3) and contain a heme group, the presumed recognition site for nitric oxide/EDRF (7) (8) (9) (10) (11) (12) (13) . By convention, the longer subunit is denoted a; the shorter subunit is denoted #(314). At present, two a and two (3 subunits have been cloned (7, 8, 10, 11, 15) . Although all a and (3 subunits contain an apparent COOH-terminal catalytic domain, they do not function independently (8, 11, 16) . Rather, co-expression oftwo subunits is required to reconstitute catalytic activity (8, 15, 16) .
From the limited data available, there is evidence of tissuespecific expression. While a l and (1 are expressed in many organs and tissues (8, 10) , a second (-subunit ((32) cloned by Yuen, Potter, and Garbers from rat kidney is preferentially expressed in rat kidney and liver ( 15) . Rat (2 is 43% homologous to rat 31 in the putative catalytic domain near the carboxyl terminus and 50% homologous to rat (31 in an amino-terminal domain which may contain the heme binding site. Recently, a second a subunit (a2) was cloned from human brain; however, its tissue distribution is unknown ( 11) . The tissuespecific distribution of (32 suggests the existence of multiple EDRF receptor heterodimers. However, the specific cellular localization and the composition of in vivo heterodimers are unknown. We used the reverse transcriptase/ polymerase chain reaction (RT/ PCR) to localize the known EDRF receptor subunit isoforms in specific portions of the kidney. This method couples the fine structural resolution obtained with renal microdissection with the extreme sensitivity of PCR ( 17, 18 described previously ( 15 (8 mm) were transferred by an albumin-coated 200-,g pipette tip to a wash solution to rinse away debris. Wash solutions were placed in disposable plastic dishes (Coming Inc., Coming, NY) to minimize contamination. The segments were attached to .25-mm glass beads (Thomas Scientific, Swedesboro, NJ), then transferred using a forceps to a 500-i1 reaction tube. To minimize cross-contamination of mRNA from tubules to blood vessels, the dissection and wash solutions did not contain RNAse inhibitors. The segments were rinsed four times with icecold dissection solution containing an RNase inhibitor (RNasin, 1 U/ Ml; Promega Corp., Madison, WI), then permeabilized with 2% Triton X-100 in the presence of RNase inhibitor. cDNA synthesis was carried out using 200 U murine Moloney leukemia virus reverse transcriptase, 5 MM oligo-dT 6, 1 mM dNTPs, and 3 mM Mg++ in a volume of 20 1d.
In some tubes, the reverse transcriptase was omitted to control for amplification from contaminating cDNA or genomic DNA. The temperature profile was: (a) annealing at room temperature for 5 min, (b) extension at 42°C for 60 min, and (c) termination at 99°C for 5 min.
The resulting segment-specific cDNA was split into four tubes, and PCR was performed using specific oligonucleotide primers and conditions indicated in Table I . PCR reactions contained: .5-2 MM primers, . c i c a E IE free energy considerations (21 ) using a computer program written by the authors. We optimized the primer location, primer concentration, Mg and annealing temperature, for each primer set to produce the greatest amount of a single PCR product.
The PCR products were size-fractionated by agarose gel electrophoresis. The DNA was transferred to nylon filters, and probed with a 32P-end-labeled internal oligonucleotide primer specific for each subunit. The prehybridization, hybridization, and washing conditions were similar to Garcia-Perez et al. (22) . Our subunit specific oligonucleotide probes do not cross-hybridize with the other known subunits.
Potential PCR primers were chosen from rat sequence information using the method ofLowe et al. (23) . To prevent amplification ofother known guanylyl cyclases, nonspecific annealing of the 3' end of each primer with other EDRF receptor subunits and the ANP A and B receptors (15, 24, 25) was checked using specially written computer software. The location ofintron/exon boundaries for the EDRF receptor isoforms are unknown. PCR primers were shown to be in separate exons by the absence of the predicted PCR product (a) in samples containing 1 utg of rat genomic DNA (data not shown), or (b) in samples containing blood vessels or tubules but lacking reverse transcriptase (see Figs. 1 and 2 ). Each primer set produced a single band of the predicted size on both agarose gels and on Southern blots ( Figs. 1 and  2 ). The (1 primer set produces a higher molecular weight product, which presumably contains at least one intron. The higher molecular weight (31 band is seen in reactions using 1-2-mm tubule, indicating that the 11 primer set is extremely sensitive (i.e., can detect -1,000 template molecules in -500 cells).
Direct sequencing ofPCR products. DNA excised from an agarose gel band was purified by glass beads, then subjected to direct double stranded sequencing (fmol PCR sequencing; Promega Corp.). We used the isoform-specific PCR primers as sequencing primers. The DNA was sequenced for 100-200 bp in each direction. cGMP accumulation. cGMP accumulation was measured as described previously (26) . Microdissected arteries were incubated for 10 min at 370C with 0.5 mM 3-isobutyl-l-methylxanthine in dissection solution. Nitroprusside (final concentration 100 ,M) or vehicle was added for 3 min. The incubation was terminated with ice-cold TCA, and the supernatant was stored at -70'C. The TCA was removed with water-saturated ether, and cGMP content was measured by radioimmunoassay (New England Nuclear, Boston, MA). In each experiment, blank samples containing medium and TCA without arteries were also taken. Each point is the mean of four tubes. Statistics. The results are given as means±SE. The differences were tested by unpaired t test. P < 0.05 was considered significant.
Results
Differential expression of EDRF receptor subunit mRNA by RT/PCR in microdissected rat renal structures. Fig. 1 shows a typical ethidium bromide stained agarose gel (top) and Southern blot analysis (bottom) of the RT/PCR amplification products from EDRF receptor subunit isoform mRNA in microdissected interlobular artery with attached afferent arteries. We consistently found the presence of a 1, a2, and iB 1 on ethidium bromide-stained gels and on Southern blots. We were surprised to find a2 by RT/PCR, since a2 could not be detected by Northern blotting using 30 ug of poly-A' RNA (data not shown). To confirm that a2 was present in this vascular segment, we performed RT/PCR using a second set of a2 primers. This primer set produced an 879-bp band of the correct predicted size, which hybridized to an internal oligonucleotide probe (results not shown). This confirms that a2 is present in the interlobular artery/afferent arteriole. A similar pattern of subunit expression was found in microdissected arcuate arteries. We also detected a very faint band for 132 by both ethidium bromide stained agarose gels and by Southern blotting in 2 of 7 independent experiments in ILA/AA. We did not detect any 132 mRNA in three similar experiments using 1-2-mm arcuate blood vessels. plification products from microdissected cortical collecting t 4* duct. We found that mRNA for a 1 and j32 were present in rat CCD. In contrast, we could not detect a2 or #1. Direct double-stranded sequencing of the specific bands Figure 1 . Ethidium bromide-stained gel (top) and Southern blot generated from microdissected renal structures indicated that (bottom) of RT/PCR products from rat interlobular artery/afferent the bands were identical to published sequences for rat a 1, #1, 
Discussion
These studies provide the first evidence that mRNA for different guanylyl cyclase-linked EDRF receptor subunits are heterogeneously expressed in renal blood vessels and the cortical collecting duct (Table II) . We also report a method for detecting several genes simultaneously. Previous studies using an RT/ PCR technique to detect gene expression in microdissected renal structures have only detected one gene at a time. We will discuss several technical issues, then discuss the implications of the results.
Specificity of PCR primers. We placed all PCR primers near the 3' end ofthe coding sequences, since this would maximize detection of cDNA transcripts prepared using oligo-dT primers. However, the four EDRF receptor subunits all contain a putative guanylyl cyclase catalytic domain at their carboxy terminus, which shares high homology with a similar region contained in the membrane bound guanylyl cyclase receptors (including ANP and heat-stable enterotoxin [1 1, 14] ). We developed computer software to find the regions ofhighest mismatch between similar genes. To minimize the possibility of detecting the wrong gene, we were careful to locate the PCR primers in unique regions. For example, the forward primers for a2, 131, and 132 were placed in the same low homology region within the presumed guanylyl cyclase catalytic site, while the reverse primers for 11 and 132 were placed in their unique carboxy terminus regions. We confirmed that the PCR products were indeed from the desired genes by two different methods: (a) We used Southern blotting with an internal oligonucleotide probe synthesized to an unique region of each isoform. This technique ensures that the PCR product contains an additional 20-25 bases of identity to the intended product. (b) More strict evidence was obtained by directly sequencing several hundred bases of each band. In all cases, the sequences agreed with those previously published for a 1,131, and 132. The deduced amino acid sequence of the a2 band agreed with the published sequence ofhuman a2. Taken together, these results establish that the PCR primers were specific for the desired genes.
Molecular composition ofheterodimeric guanylyl cyclaselinked EDRF receptors. By performing four PCR reactions in parallel on the same sample, we were able to co-localize the expression of EDRF receptor subunits. This is important, since the guanylyl cyclase-linked EDRF receptor is a heterodimer. When expressed alone, all four subunits are inactive, and not stimulated by nitroprusside (8, 11, 15, 16) . Co-expression of a I /131 or a2 /13 results in enzyme which is stimulated by nitroprusside (8, 11, 16) , suggesting that dimerization is required for formation of an active catalytic site. Thus, at least several different heterodimeric EDRF receptors could exist in vivo: cell, this raises the intriguing possibility that the level ofa2 could modulate guanylyl cyclase activity. Indeed, a recent study has shown that'human a2/bovine 13 heterodimer appears less active than a bovine al/bovine ,13 heterodimer (11). It is uncertain whether this is caused by intrinsic differences in enzyme activity, subtle species differences, or unequal expression of a 1 / 31 vs a2/13l.
Expression of mRNA for the a2 EDRF receptor was easily detected by RT/PCR in microdissected interlobular arteries/ afferent arterioles (Fig. 2) , but not by Northern blotting with random-hexamer primed probes. Northern blotting may not detect gene expression if the message is of low abundance, or localized to a rare compartment. Because ofits high sensitivity, PCR is routinely employed to detect gene expression of rare transcripts. These studies show the synergistic methods of microdissection and PCR can be used to localize mRNA species expressed in small portions of an organ.
Nitroprusside-stimulated cGMP accumulation has been detected in microdissected rat CCD and cultured mouse CCD cells (6, 29) . Recently, EDRF released from endothelial cells decreased the short-circuit current in mouse CCD cells (6 co-expression studies should be useful in determining if these EDRF receptors exhibit different sensitivity to EDRF and related compounds, or subserve different functions.
